Ozemback
Science

The evidence on peptides and metabolic drugs, read against the trials

This desk reads the trial evidence directly. Where the data is strong we say so, where it is a handful of small studies we say that too, and where the forums have run far ahead of the literature we mark the gap instead of splitting the difference.

The distance between what a compound is claimed to do and what has been measured in a controlled trial is, for most peptides, very large.

16 articles in this desk
Ozemback is independent journalism. Nothing on this site is medical advice. Nothing replaces a licensed clinician. Read the disclaimer